Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hofseth BioCare ASAHOFBF 61 3-Year EBITDA Growth Rate is 12.10% as of Jun. 2026, which is 70% above its 10-year median of 7.10. GuruFocus rates HOFBF with a GF Score™ of 61/100 and a GF Value™ of $0.22. The stock has 5 warning signs investors should review. Among 1,665 Consumer Packaged Goods companies, Hofseth BioCare ASA ranks better than 57.42% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 12.10% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 6.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hofseth BioCare ASA was 38.90% per year. The lowest was -18.30% per year. And the median was 7.10% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Hofseth BioCare ASA 3-Year EBITDA Growth Rate Related Terms
HOFBF vs KHC, GIS, HRL: 3-Year EBITDA Growth Rate Comparison
For the Packaged Foods subindustry, Hofseth BioCare ASA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hofseth BioCare ASA 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Hofseth BioCare ASA's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Hofseth BioCare ASA's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 12.10% mean?
Hofseth BioCare ASA (HOFBF) has a 3-Year EBITDA Growth Rate of 12.10% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Hofseth BioCare ASA and its competitors. This is 70% above median its historical median of 7.10. According to the industry distribution chart, Hofseth BioCare ASA ranks #709 out of 1665 companies in the Consumer Packaged Goods industry, placing it in the top 42.6%.
Is Hofseth BioCare ASA's 3-Year EBITDA Growth Rate too high?
Hofseth BioCare ASA's current 3-Year EBITDA Growth Rate of 12.10% is 70% above median its 10-year median of 7.10. The Consumer Packaged Goods industry median 3-Year EBITDA Growth Rate is 8.20. Hofseth BioCare ASA's value of 12.10% is 47.6% above this industry median. Based on the distribution chart, Hofseth BioCare ASA ranks #709 out of 1665 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Hofseth BioCare ASA has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Hofseth BioCare ASA's 3-Year EBITDA Growth Rate compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hofseth BioCare ASA ranks #709 out of 1665 companies for 3-Year EBITDA Growth Rate. This puts Hofseth BioCare ASA in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.20. Hofseth BioCare ASA's value of 12.10% is 47.6% above this benchmark. While the company's 10-year median is 7.10 vs. the industry median of 8.20, Hofseth BioCare ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 8.20, based on 1,665 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hofseth BioCare ASA's current 3-Year EBITDA Growth Rate of 12.10% is 47.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Hofseth BioCare ASA and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hofseth BioCare ASA's current 3-Year EBITDA Growth Rate is 12.10%, which is 70% above median its own 10-year median of 7.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hofseth BioCare ASA stock overvalued right now?
Hofseth BioCare ASA (HOFBF) has a current 3-Year EBITDA Growth Rate of 12.10%. The stock's GF Value™ is $0.22, compared to a current price of $0.17 — trading 24.3% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 12.10%, which is 70% above median its 10-year median of 7.10 and 47.6% above the Consumer Packaged Goods industry median of 8.20. Hofseth BioCare ASA's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Hofseth BioCare ASA (HOFBF), the current 3-Year EBITDA Growth Rate is 12.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hofseth BioCare ASA (HOFBF) Overvalued in 2026?
Based on GuruFocus' analysis, Hofseth BioCare ASA stock appears to be undervalued.
The current stock price of $0.17 is trading 24.3% below its estimated GF Value™ of $0.22.
Key valuation signals for HOFBF:
3-Year EBITDA Growth Rate: 12.10% (70% above median its 10-year median of 7.10)
GF Value™: $0.22 vs. price of $0.17 (24.3% below fair value)
Industry Position: 47.6% above the Consumer Packaged Goods median (#709 of 1665)
No single metric tells the full story. See the HOFBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
61GF Score
Get the complete analysis for HOFBF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HOFBF has been successfully added to your 
